The quest for a herpes simplex virus vaccine: background and recent developments.
Herpes simplex virus infections in humans range from localized skin infections of the oral, ocular and genital regions, to severe and often fatal disseminated infections of immunocompromised hosts. Following primary infection, the virus often becomes established in a latent form in the neurons of sensory ganglia and can reactivate to excrete virus asymptomatically or produce recrudescent lesions. This review describes some of the mechanisms involved in the immune response against HSV infections and examines the different strategies adopted to develop a vaccine against this seemingly intractable disease.
D000818:Animals; D006561:Herpes Simplex / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D018139:Simplexvirus / Q000276:immunology*; D014611:Vaccination; D014613:Vaccines, Attenuated; D014765:Viral Vaccines
D014613:Vaccines, Attenuated; D014765:Viral Vaccines